Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Learn why index funds are a popular choice for retirement, offering broad market exposure, low fees, and straightforward, scalable strategy.
24,587 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
Rigetti Computing led gains as quantum optimism returned to the front pages, helping propel the stock market today hi...
SpaceX aims to push humanity beyond Earth, and its IPO could redefine tech investing. This guide breaks down how mult...
Venice AI has secured $65 million in a Series A round led by Dragonfly, valuing the company at $1 billion as it expan...
The lure of a cheap rental property can tempt beginners, but the real challenge lies in financing and hidden costs. T...
Oracle’s 2026 story blends a sharp stock pullback with strong earnings momentum. Learn what’s driving the 18% drop, w...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
Investors weigh a massive AI financing move and its impact on a major server maker’s backlog. This piece explains wha...
A high-profile trademark dispute around the 1587 Prime restaurant tests more than litigation—it tests how branding, c...
In 2026, some markets will heat up while others cool down. This guide outlines the 10 markets where prices will rise ...